This article is a correction to:
Application of a multispecies probiotic reduces gastro-intestinal discomfort and induces microbial changes after colonoscopy
Joachim Labenz1*Daniela-Patricia Borkenstein1Franz Josef Heil2Ahmed Madisch3,4Ulrich Tappe5Harald Schmidt6
Birgit Terjung7
Ingeborg Klymiuk8
Angela Horvath9,10Manfred Gross11Vanessa Stadlbauer9,10- 1Department of Internal Medicine, Diakonie Klinikum Jung-Stilling, Siegen, Germany
- 2Praxis Dr. Heil und Dr. Müller, Andernach, Germany
- 3Department of Internal Medicine I, Hospital Clinic Siloah, Hannover, Germany
- 4Centrum Gastroenterologie Bethanien, Agaplesion Krankenhaus Bethanien, Frankfurt, Germany
- 5Gastropraxis an der St. Barbara Klinik, Hamm, Germany
- 6Praxis für Innere Medizin und Gastroenterologie Dr. H. Schmidt, Berlin, Germany
- 7GFO Kliniken Bonn, St. Josef-Hospital, Bonn, Germany
- 8Division of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center, Medical University of Graz, Graz, Austria
- 9Division for Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
- 10Area 3 Microbiome Modulation for Precision Medicine, Center for Biomarker Research in Medicine (CBmed), Graz, Austria
- 11Department of Internal Medicine, Internistisches Klinikum München Süd, Munich, Germany
A corrigendum on
Application of a multispecies probiotic reduces gastro-intestinal discomfort and induces microbial changes after colonoscopy
by Labenz J, Borkenstein D-P, Heil FJ, Madisch A, Tappe U, Schmidt H, Terjung B, Klymiuk I, Horvath A, Gross M and Stadlbauer V (2023) Front. Oncol. 12:1078315. doi: 10.3389/fonc.2022.1078315
A correction has been made to Material and methods, Participants, multispecies probiotic and placebo formulation, paragraph 1.
This sentence previously stated:
“The probiotic group received the multispecies probiotic formulation containing 3g of Bifidobacterium bifidum W23, Bifidobacterium lactis W51, Enterococcus faecium W54, Lactobacillus acidophilus W37, Lactobacillus rhamnosus WGG, Lactococcus lactis W19 at a concentration of 9x109 cfu/g in a matrix of rice starch, maltodextrin, hydrolyzed rice protein, potassium chloride, manganese sulfate and magnesium sulfate (OMNi BiOTiC® Colonize) twice daily over 30 days.”
The corrected sentence appears below:
“The probiotic group received the multispecies probiotic formulation containing 3g of Bifidobacterium bifidum W23, Bifidobacterium lactis W51, Enterococcus faecium W54, Lactobacillus acidophilus W37, Lactobacillus rhamnosus WGG, Lactococcus lactis W19 at a concentration of 3x109 cfu/g in a matrix of rice starch, maltodextrin, hydrolyzed rice protein, potassium chloride, manganese sulfate and magnesium sulfate (OMNi BiOTiC® Colonize) twice daily over 30 days.”
A correction has been made to Discussion, paragraph 10. The sentence previously stated:
“In conclusion we demonstrated in a randomized, placebo controlled, double-blind study conducted in a homogenous population undergoing screening colonoscopy that the application of a multispecies probiotic at a concentration of 2x109 cfu/g with 6 g per day starting right after colonoscopy, ameliorates side effects of colonoscopy induced constipation significantly.”
The corrected sentence appears below:
“In conclusion we demonstrated in a randomized, placebo controlled, double-blind study conducted in a homogenous population undergoing screening colonoscopy that the application of a multispecies probiotic at a concentration of 3x109 cfu/g with 6 g per day starting right after colonoscopy, ameliorates side effects of colonoscopy induced constipation significantly.”
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: adverse events, colonization, colonoscopy, colorectal cancer, prevention
Citation: Labenz J, Borkenstein D-P, Heil FJ, Madisch A, Tappe U, Schmidt H, Terjung B, Klymiuk I, Horvath A, Gross M and Stadlbauer V (2024) Corrigendum: Application of a multispecies probiotic reduces gastro-intestinal discomfort and induces microbial changes after colonoscopy. Front. Oncol. 14:1395635. doi: 10.3389/fonc.2024.1395635
Received: 04 March 2024; Accepted: 11 March 2024;
Published: 27 March 2024.
Edited and Reviewed by:
ADITI BANERJEE, University of Maryland, United StatesCopyright © 2024 Labenz, Borkenstein, Heil, Madisch, Tappe, Schmidt, Terjung, Klymiuk, Horvath, Gross and Stadlbauer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Joachim Labenz, aW5mb0Bqb2FjaGltLWxhYmVuei5kZQ==